...
首页> 外文期刊>Journal of Gynecologic Oncology >Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study
【24h】

Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study

机译:韩国宫颈细胞异常宫颈细胞学中HPV感染妇女的HPV疫苗接种现状:多中心,回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives Since 2007, human papillomavirus (HPV) vaccines have been administered for the prevention of cervical cancer in Korea. We investigated the status of HPV vaccination among HPV-infected adult women with abnormal cervical cytology before the introduction of National Immunization Program. Methods From 2010 to 2016, HPV-positive women (age, 20–60 years) with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion (LSIL) were enrolled from five hospitals across Korea. Their HPV genotype, epidemiologic, and clinical data, including HPV vaccination history, were obtained. We compared the epidemiological characteristics and prevalence of HPV-16/18 genotypes between vaccinated and unvaccinated women. Results Among the 1,300 women, approximately 26% had a history of vaccination. Vaccinated patients were significantly younger, unmarried, and had a higher education level than unvaccinated women. For HPV-vaccinated individuals by vaccine dose, there was a significant younger age at vaccination initiation (p=0.025), longer duration from HPV vaccination to Pap test date (p=0.001), and lower proportion of HPV-16/18 (p=0.028) in the women with three doses. There was a significantly lower prevalence of HPV-16/18 genotypes in women who were vaccinated at least 12 months prior than in unvaccinated women (adjusted prevalence ratio [aPR]=0.51; 95% confidence interval [CI]=0.29–0.88). For women with LSIL, the prevalence of the HPV-16/18 genotypes was significantly lower in women who were vaccinated more than 12 months prior than in unvaccinated women (aPR=0.35; 95% CI=0.13–0.96). Conclusion This study highlighted the status of HPV vaccination and the prevalence of HPV-16/18 genotypes among HPV-infected women with abnormal cervical cytology according to HPV vaccination. It provides preliminary information regarding the status of HPV vaccination among Korean adult women.
机译:目的自2007年以来,人乳头瘤病毒(HPV)疫苗已被施用用于预防韩国的宫颈癌。在引入国家免疫计划之前,我们调查了HPV感染的成人女性中HPV感染的成年女性的HPV疫苗接种状态。方法从2010年到2016年,HPV阳性妇女(年龄,20-60岁),非典型意义或低级鳞状上皮病变(LSIL)的鳞片细胞(LSIL)均以韩国五位医院注册。获得其HPV基因型,流行病学和包括HPV疫苗接种历史的临床数据。我们比较了疫苗和未接种疫苗的妇女之间的流行病学特征和HPV-16/18基因型的患病率。结果在1,300名女性中,约26%的疫苗历史。疫苗接种的患者显着年轻,未婚,并且具有比未接种疫苗的妇女更高的教育水平。对于通过疫苗剂量的HPV接种疫苗的个体,疫苗接种引发(P = 0.025),从HPV疫苗接种的持续时间较长,从HPV疫苗接种到PAP试验日(P = 0.001),以及较低比例的HPV-16/18(P = 0.028)患有三剂量的女性。在除非未接种的妇女疫苗(调整患病率(调整患病率)疫苗接种至少12个月的女性中,患有至少12个月的妇女的患病率显着降低对于患有LSIL的女性,在未接种妇女疫苗前超过12个月的女性患有HPV-16/18基因型的患病率显着降低(APR = 0.35; 95%CI = 0.13-0.96)。结论本研究强调了HPV疫苗接种的状态和HPV-16/18基因型的患病率,根据HPV疫苗接种宫颈细胞学异常具有异常的宫颈细胞学。它提供有关韩国成年女性HPV疫苗接种状态的初步信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号